Vaccine May Protect Against Bird Flu
Posted on: Saturday, 19 April 2008, 00:00 CDT
A vaccine under development may provide protection against highly pathogenic bird flu and its evolving forms, U.S. researchers suggest.
Researchers at Purdue University and the Centers for Disease Control and Prevention in Atlanta say, unlike traditional influenza vaccines, the new vaccine could be produced quickly and stored for long periods in preparation for a pandemic.
Purdue virologist Suresh Mittal and colleagues have found that the vaccine protected against avian flu H5N1 for a year or longer. Because the studies have only been done in mice, it's not yet known whether the same results will be obtained in humans, Mittal said.
One of the problems with current influenza vaccines is that they are made from eggs, a process that can take as long as six months. But the vaccine Mittal and his research team have developed isn't grown in eggs, making vaccine production much faster.
The new vaccine uses an adjuvant -- molecules added to the vaccine that stimulate the body's immune system -- so lower doses of the vaccine can be used. The adjuvant also allows the vaccine to be stockpiled so more people can be vaccinated, and it helps the vaccine protect against variant forms of the H5N1.
The findings are published in The Journal of Infectious Diseases.
Source: United Press International
Related Articles
- Photo: Families Fighting Flu and CDC Encourage Parents to Vaccinate Kids Against Flu
- Families Fighting Flu and CDC Encourage Parents to Vaccinate Kids Against Flu
- EndoBiologics, Incorporated, and PATH Form New Collaboration to Research Vaccine Candidates Against Diarrheal Disease
- Flu Vaccine Protects Against Only 27% of Texas Cases
- GSK's Vaccine Protects Against Bird Flu
- Vaccine Approved Against Cervical Cancer
- PowderMed's DNA-Based Flu Vaccine Shows Cross-Protective Immunity Against Genetically-Drifted Flu Strains, Offering Potential for Vaccine Effective Against Emerging Flu Variants
- Britain Plans to Vaccinate People Against Bird Flu
- Mozambique Launches Vaccination Campaign Against Measles, Polio
- Pneumonia Vaccine Protects Against Flu Complications
 |
 |
User Comments (1)
| 1. |
Posted by MWilhelm on 06/16/2008, 17:16 The World Health Organization (WHO) and others continue to express concern over the growing threat of pandemic influenza, despite the media’s declining coverage of bird flu (Avian Influenza). Although it’s encouraging that there are cell-based vaccines under development that show great potential, the question remains: can we make enough in time to treat everyone? Vaccine adjuvants should be a vital part of any preparedness strategy. By combining the right adjuvant and vaccine during development, potentially more people can be treated with the same amount of vaccine. Homspera is a promising adjuvant under development by our Scottsdale-based biotech company, ImmuneRegen. |
RSS Feeds